Literature DB >> 12548293

A digestive tolerance study of maltitol after occasional and regular consumption in healthy humans.

A Ruskoné-Fourmestraux1, A Attar, D Chassard, B Coffin, F Bornet, Y Bouhnik.   

Abstract

AIM: We aimed to evaluate the gastro-intestinal tolerance to an indigestible bulking sweetener containing sugar alcohol using a double-blind random cross-over study.
METHOD: In order to simulate their usual pattern of consumption, 12 healthy volunteers ingested maltitol or sucrose throughout the day, either occasionally (once a week for each sugar, first period) or regularly (every day for two 9 day periods, second period). In both patterns of consumption, daily sugar doses were increased until diarrhea and/or a grade 3 (ie severe) digestive symptom occurred, at which the dose level was defined as the threshold dose (TD).
RESULTS: In the first period (occasional consumption), the mean TD was 92+/-6 g with maltitol and 106+/-4 g with sucrose (P=0.059). The mean intensity of digestive symptoms was 1.1 and 1.3, respectively (P=NS). Diarrhea appeared in six and one subjects respectively (P=0.035). In the second period (regular consumption), the mean TD was 93+/-9 g with maltitol and 113+/-7 g with sucrose (P=0.008). The mean intensity of digestive symptoms was 1.7 and 1.2, respectively (P=NS). However, diarrhea appeared in eight and three subjects, respectively (P=0.04). Maltitol and sucrose TDs between the two periods were not different.
CONCLUSIONS: Under our experimental conditions, in comparison to sucrose: (a) occasional or regular consumption of maltitol is not associated with severe digestive symptoms; (b) in both patterns of maltitol consumption, diarrhea frequency is higher, but it appeared only for very high doses of maltitol, much greater than those currently used; (c) maltitol does not lead to intestinal flora adaptation after a 9 day period of consumption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548293     DOI: 10.1038/sj.ejcn.1601516

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  7 in total

1.  Glycaemia and phosphatemia after oral glucose and maltitol ingestion in subjects from two different race groups: preliminary evidence of inter-race differences in metabolism and possible implications for urinary stone disease.

Authors:  Takalani Theka; Allen Rodgers
Journal:  Int Urol Nephrol       Date:  2017-05-19       Impact factor: 2.370

Review 2.  Suitability of sugar alcohols as antidiabetic supplements: A review.

Authors:  Nontokozo Z Msomi; Ochuko L Erukainure; Md Shahidul Islam
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

3.  Acute diarrhea during army field exercise in southern China.

Authors:  Yang Bai; Ying-Chun Dai; Jian-Dong Li; Jun Nie; Qing Chen; Hong Wang; Yong-Yu Rui; Ya-Li Zhang; Shou-Yi Yu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 4.  Gastrointestinal Disturbances Associated with the Consumption of Sugar Alcohols with Special Consideration of Xylitol: Scientific Review and Instructions for Dentists and Other Health-Care Professionals.

Authors:  Kauko K Mäkinen
Journal:  Int J Dent       Date:  2016-10-20

5.  Gastrointestinal Tolerance and Glycemic Response of Isomaltooligosaccharides in Healthy Adults.

Authors:  Vishnupriya Gourineni; Maria L Stewart; Didem Icoz; J Paul Zimmer
Journal:  Nutrients       Date:  2018-03-03       Impact factor: 5.717

6.  Suppressive response of confections containing the extractive from leaves of Morus Alba on postprandial blood glucose and insulin in healthy human subjects.

Authors:  Mariko Nakamura; Sadako Nakamura; Tsuneyuki Oku
Journal:  Nutr Metab (Lond)       Date:  2009-07-14       Impact factor: 4.169

7.  Digestive tolerance and postprandial glycaemic and insulinaemic responses after consumption of dairy desserts containing maltitol and fructo-oligosaccharides in adults.

Authors:  F Respondek; C Hilpipre; P Chauveau; M Cazaubiel; D Gendre; C Maudet; A Wagner
Journal:  Eur J Clin Nutr       Date:  2014-03-19       Impact factor: 4.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.